Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
Turnium and Syntheia AI Commence Commercial Rollout of AI-Powered Communications Platform Across Partner Network